Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
NMSC therapy Remove


May 2022
MoSuSaFrThWeTu
16151413121110

Public Company News

Business Press Releases

NMSC Therapy Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12913111
By OncoBeta GmbH
OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT – for the treatment of non-melanoma skin cancer [NMSC]).
12909107
By OncoBeta GmbH
OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT– for the treatment of non-melanoma skin cancer). Prof. Dr.
12908561
By OncoBeta GmbH
OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part of the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT – for the treatment of...
12905084
By OncoBeta GmbH
The International Registry is an observational, multicentre, non-interventional program for patients diagnosed with non-melanoma skin cancer (NMSC), to inform treatment outcomes and patterns of care at international hospitals.
12898396
By OncoBeta GmbH
OncoBeta® GmbH, a medical device company specialized in innovative epidermal radioisotope therapies announced today that the company has received ethics approval from the National Health and Medical Research Council (NHMRC) in Australia to begin the...
12893836
By OncoBeta GmbH
Today OncoBeta® GmbH, a medical device company specialising in innovative epidermal radioisotope therapies for non-melanoma skin cancers (NMSCs), has expanded its offering of non-invasive skin cancer therapy Rhenium-SCT® (Skin Cancer Therapy) in South...
12877245
By OncoBeta GmbH
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
12839702
By OncoBeta GmbH
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer to be produced in Australia
12838058
By OncoBeta GmbH
Grupo RPH is now the Official Rhenium-SCT® Sales Representative and Distributor in Brazil for the treatment of Non-Melanoma Skin Cancer.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share